Guangzhou Jet Bio-filtration (688026.SH) disclosed its semi-annual report for 2024, and the company achieved revenue of 2.36 billion yuan during the reporting period...
According to the semi-annual report for 2024 released by Guangzhou Jet Bio-filtration (688026.SH), the company achieved revenue of 0.236 billion yuan during the reporting period, with a year-on-year growth of 20.14%; the net income attributable to the shareholders of the listed company was 30 million yuan, with a year-on-year growth of 912.89%; the non-recurring net income was 25.39 million yuan, with a year-on-year growth of 3229.7%; the basic earnings per share was 0.23 yuan.
The increase in revenue, net profit attributable to the shareholders of the listed company, and net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses in the same period of the previous year were 20.14%, 912.89%, 3,229.70% respectively, mainly due to the increase in sales revenue and the rise in gross margin during the reporting period.
The net cash flow from operating activities decreased by 59.01% compared to the same period of the previous year, mainly due to the company's strategic reserves and the increase in prepayments for raw materials. The net assets attributable to the shareholders of the listed company and the total assets decreased by 0.13% and 0.08% respectively compared to the end of the previous year, mainly due to the repurchase of shares and dividends during the reporting period.